Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy
- 25 August 2007
- journal article
- case report
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 25 (5) , 333-336
- https://doi.org/10.1007/s00774-007-0771-y
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Changes in biochemical markers of bone in patients with insufficiency fracturesJournal of Bone and Mineral Metabolism, 2004
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenNew England Journal of Medicine, 2004
- Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometryCurrent Opinion in Nephrology and Hypertension, 2003
- Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog RibJournal of Bone and Mineral Research, 2000
- Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosisThe American Journal of Medicine, 1996
- Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisBone, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal femalesJournal of Bone and Mineral Research, 1988
- Pubic and sacral insufficiency fractures: clinical course and radiologic findingsAmerican Journal of Roentgenology, 1985
- Effects of differences in mineralization on the mechanical properties of bonePhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1984